← FDA Drug Approvals (Drugs@FDA)
AZACITIDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2022-02-03
Drug application
- FDA Application #
ANDA211549- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AZACITIDINE
- Generic name
- AZACITIDINE
- Active ingredients
- AZACITIDINE
- Dosage form
- POWDER
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Discontinued
- Sponsor
- AMNEAL
- Manufacturer
- Amneal Pharmaceuticals LLC
- First approval
- 2022-02-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown